A detailed history of Geode Capital Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 13,521,147 shares of EW stock, worth $899 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
13,521,147
Previous 13,236,229 2.15%
Holding current value
$899 Million
Previous $1.22 Billion 27.02%
% of portfolio
0.07%
Previous 0.11%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$59.7 - $93.78 $17 Million - $26.7 Million
284,918 Added 2.15%
13,521,147 $892 Million
Q2 2024

Aug 09, 2024

BUY
$84.3 - $94.31 $11.9 Million - $13.4 Million
141,603 Added 1.08%
13,236,229 $1.22 Billion
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $16.4 Million - $21.6 Million
226,482 Added 1.76%
13,094,626 $1.25 Billion
Q4 2023

Feb 13, 2024

BUY
$61.71 - $77.76 $10.9 Million - $13.7 Million
176,345 Added 1.39%
12,868,144 $981 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $19.4 Million - $26.1 Million
279,749 Added 2.25%
12,691,799 $879 Million
Q2 2023

Aug 11, 2023

BUY
$81.41 - $94.33 $16.1 Million - $18.6 Million
197,431 Added 1.62%
12,412,050 $1.17 Billion
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $5.82 Million - $6.62 Million
78,376 Added 0.65%
12,214,619 $1.01 Billion
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $14.1 Million - $18 Million
205,714 Added 1.72%
12,136,243 $904 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $16.4 Million - $21.4 Million
199,365 Added 1.7%
11,930,529 $985 Million
Q2 2022

Aug 12, 2022

BUY
$86.5 - $128.27 $23.6 Million - $35 Million
272,554 Added 2.38%
11,731,164 $1.11 Billion
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $36.6 Million - $46 Million
358,768 Added 3.23%
11,458,610 $1.35 Billion
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $55 Million - $67.6 Million
517,261 Added 4.89%
11,099,842 $1.43 Billion
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $36.8 Million - $43.9 Million
358,020 Added 3.5%
10,582,581 $1.19 Billion
Q2 2021

Aug 13, 2021

BUY
$83.84 - $104.76 $26.2 Million - $32.7 Million
312,507 Added 3.15%
10,224,561 $1.06 Billion
Q1 2021

May 12, 2021

BUY
$78.68 - $90.67 $9.65 Million - $11.1 Million
122,660 Added 1.25%
9,912,054 $827 Million
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $17.1 Million - $21.8 Million
-238,879 Reduced 2.38%
9,789,394 $891 Million
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $8.37 Million - $10.9 Million
-124,541 Reduced 1.23%
10,028,273 $799 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $387 Million - $517 Million
6,723,733 Added 196.08%
10,152,814 $700 Million
Q1 2020

May 14, 2020

SELL
$52.41 - $81.0 $4.35 Million - $6.73 Million
-83,068 Reduced 2.37%
3,429,081 $646 Million
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $15.1 Million - $17.3 Million
210,206 Added 6.37%
3,512,149 $818 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $34.7 Million - $42.5 Million
563,677 Added 20.59%
3,301,943 $725 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $11 Million - $12.7 Million
-197,498 Reduced 6.73%
2,738,266 $505 Million
Q1 2019

May 14, 2019

SELL
$47.89 - $64.05 $322,299 - $431,056
-6,730 Reduced 0.23%
2,935,764 $561 Million
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $9.39 Million - $11.5 Million
202,248 Added 7.38%
2,942,494 $450 Million
Q3 2018

Nov 13, 2018

BUY
$45.7 - $58.03 $3.61 Million - $4.58 Million
78,928 Added 2.97%
2,740,246 $476 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $4.54 Million - $5.49 Million
106,940 Added 4.19%
2,661,318 $387 Million
Q1 2018

May 15, 2018

BUY
$37.19 - $47.45 $5.66 Million - $7.22 Million
152,169 Added 6.33%
2,554,378 $356 Million
Q4 2017

Feb 13, 2018

BUY
$33.79 - $39.39 $3.14 Million - $3.67 Million
93,049 Added 4.03%
2,402,209 $270 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $2.22 Million - $2.38 Million
61,244 Added 2.72%
2,309,160 $252 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,247,916
2,247,916 $265 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.